Junichi Azuma

1. NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy
   2012/11/13 by Junichi Azuma, Masako Ohno, Ryuji Kubota +8 · 2 citations
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Drug-Induced Hepatotoxicity and Protection #Malaria Research and Control #Tuberculosis Research and Epidemiology